← Open Payments lookup

PIUS EFOBI: Open Payments

NPI 1306538707 · LONG BRANCH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,324 in 147 payments from 11 companies in 2025. Trend: 2023 $192 · 2024 $2,512 · 2025 $2,324

Food & beverage: $2,212Education: $111
CompanyPaymentsAmount
ABBVIE INC.77$761
Otsuka America Pharmaceutical, Inc.15$299
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$293
Alkermes, Inc.8$260
Teva Pharmaceuticals USA, Inc.10$218
Janssen Pharmaceuticals, Inc9$171
Neurocrine BioSciences, Inc.5$106
Axsome Therapeutics, Inc.4$72
Vanda Pharmaceuticals Inc.4$66
E.R. Squibb & Sons, L.L.C.3$61

Products named: VRAYLAR, CAPLYTA, REXULTI, LYBALVI, SPRAVATO, INGREZZA, AUSTEDO XR, ARISTADA.

Industry payments across NJ — which companies pay providers there.